AbCellera Biologics Inc.ABCLNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank85
5Y CAGR-63.1%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-63.1%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 62.53% |
| Q3 2025 | -53.83% |
| Q2 2025 | 20.87% |
| Q1 2025 | 13.88% |
| Q4 2024 | 22.32% |
| Q3 2024 | -0.22% |
| Q2 2024 | -70.24% |
| Q1 2024 | 16.89% |
| Q4 2023 | -20.34% |
| Q3 2023 | -6.81% |
| Q2 2023 | 20.79% |
| Q1 2023 | -71.72% |
| Q4 2022 | -200.11% |
| Q3 2022 | 549.44% |
| Q2 2022 | -103.73% |
| Q1 2022 | 175.83% |
| Q4 2021 | 390.27% |
| Q3 2021 | -299.49% |
| Q2 2021 | -104.45% |
| Q1 2021 | -1.68% |
| Q4 2020 | 9193.57% |
| Q3 2020 | -107.03% |
| Q2 2020 | 59.75% |
| Q1 2020 | -7.39% |
| Q4 2019 | -176.15% |
| Q3 2019 | -0.40% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |